This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for thrombectomy systems for ischemic stroke. This market, as covered by the scope of this analysis, includes stent retrievers and aspiration systems. Geographic areas covered by this analysis include the US, the five major EU markets, Japan, and the rest of the world. This report is part of a series of reports covering the interventional neurology market for stroke treatments.
This report provides the following useful information:
- Clinical overview of thrombectomy procedures for intracranial applications
- Incidence and prevalence data for ischemic stroke
- Product portfolios offered by leading manufacturers
- Top-selling devices, as well as emerging products
- In depth market and competitive analyses
Report Highlights
- There are approximately 10.3 million incidents of stroke worldwide, with ischemic stroke accounting for two-thirds of cases.
- The combined global market for thrombectomy systems for ischemic stroke is projected to climb approximately 13% over the forecast period , reaching $790m in 2022.
- The greatest growth is projected for the aspiration systems product segment, which has benefited from newly released clinical trial data.
- Three competitors – Medtronic, Penumbra, and Stryker – hold nearly 90% of the market for thrombectomy systems for ischemic stroke.
Key Questions Answered
- What are the key drivers and limiters for the ischemic stroke products market?
- Which competitors are leading the market and introducing new technology?
- How are technological advancements impacting market growth?
- Which areas of the market are experiencing dynamic growth?
- How are mergers and acquisitions affecting the market shares of leading competitors?
Table of Contents
1. Executive Summary
Exhibit ES-1: Thrombectomy systems for ischemic stroke, market forecast, by country/region, 2017-22
Intracranial Thrombectomy Systems
The Market for Thrombectomy Systems for Ischemic Stroke
